Approved Hospital Formulary
Suggestions or Corrections? Above and Beyond Nominations Formulary Request
Show Therapeutic Classes
QR Code Add Formweb to your mobile device
Android iOS
Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Approved Hospital Formulary
Suggestions or Corrections? Above and Beyond Nominations Formulary Request
Search results for:

iohexol

iohexol
  • Formulary
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Omnipaque 240 SOLUTION, INJECTABLE 240 mg/mL      
Omnipaque 300 SOLUTION, INJECTABLE 300 mg/mL      
Omnipaque 350 SOLUTION, INJECTABLE 350 mg/mL      
VIEW MORE Roentgenographic and Other Imaging Agents
Comments:

Category A Vesicant: See Management of Extravasation of Irritant and Vesicant Drugs (Non-Chemotherapy) - ADULTS and Management of Extravasation of Irritant and Vesicant Drugs (Non-Chemotherapy) PEDIATRIC

Powerplans: HOSP Vesicant Extravasation Management Orders and PEDS Vesicant Extravasation Management Orders

 

Dilution instructions for Omnipaque 240 in ADULT patients: Mix with 32 oz of fluid. Nursing also receives a medication alert with dilution instructions when pulling from Pyxis.

Dilution instructions for Omnipaque 240 in PEDIATRIC patients: Refer to Omnipaque Guidelines in Children

Last updated: May. 13, 2026






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2026 Rpharmy, LLC ­ All Rights Reserved